- Home
- ESEA vs CMPX Comparison
ESEA vs CMPX Comparison
Compare ESEA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- CMPX
- Stock Information
- Founded
- ESEA 2005
- CMPX 2014
- Country
- ESEA Greece
- CMPX United States
- Employees
- ESEA N/A
- CMPX N/A
- Industry
- ESEA Marine Transportation
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- CMPX Health Care
- Exchange
- ESEA Nasdaq
- CMPX Nasdaq
- Market Cap
- ESEA 253.9M
- CMPX 214.6M
- IPO Year
- ESEA 2006
- CMPX N/A
- Fundamental
- Price
- ESEA $33.01
- CMPX $2.60
- Analyst Decision
- ESEA Buy
- CMPX Strong Buy
- Analyst Count
- ESEA 1
- CMPX 4
- Target Price
- ESEA $53.00
- CMPX $13.75
- AVG Volume (30 Days)
- ESEA 49.1K
- CMPX 2.2M
- Earning Date
- ESEA 02-19-2025
- CMPX 11-12-2024
- Dividend Yield
- ESEA 7.27%
- CMPX N/A
- EPS Growth
- ESEA 3.12
- CMPX N/A
- EPS
- ESEA 16.28
- CMPX N/A
- Revenue
- ESEA $208,648,067.00
- CMPX $850,000.00
- Revenue This Year
- ESEA $14.91
- CMPX N/A
- Revenue Next Year
- ESEA $7.13
- CMPX $613.39
- P/E Ratio
- ESEA $2.03
- CMPX N/A
- Revenue Growth
- ESEA 13.90
- CMPX N/A
- 52 Week Low
- ESEA $31.14
- CMPX $0.77
- 52 Week High
- ESEA $50.92
- CMPX $2.70
- Technical
- Relative Strength Index (RSI)
- ESEA 35.46
- CMPX 76.97
- Support Level
- ESEA $33.80
- CMPX $1.43
- Resistance Level
- ESEA $34.70
- CMPX $2.70
- Average True Range (ATR)
- ESEA 1.24
- CMPX 0.29
- MACD
- ESEA -0.03
- CMPX 0.12
- Stochastic Oscillator
- ESEA 4.55
- CMPX 92.31
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.